Cardiotoxicity: Difference between revisions
No edit summary |
(No difference)
|
Revision as of 21:23, 22 April 2009
WikiDoc Resources for Cardiotoxicity |
Articles |
---|
Most recent articles on Cardiotoxicity Most cited articles on Cardiotoxicity |
Media |
Powerpoint slides on Cardiotoxicity |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cardiotoxicity at Clinical Trials.gov Trial results on Cardiotoxicity Clinical Trials on Cardiotoxicity at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cardiotoxicity NICE Guidance on Cardiotoxicity
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cardiotoxicity Discussion groups on Cardiotoxicity Patient Handouts on Cardiotoxicity Directions to Hospitals Treating Cardiotoxicity Risk calculators and risk factors for Cardiotoxicity
|
Healthcare Provider Resources |
Causes & Risk Factors for Cardiotoxicity |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Cardiology Network |
Discuss Cardiotoxicity further in the WikiDoc Cardiology Network |
Adult Congenital |
---|
Biomarkers |
Cardiac Rehabilitation |
Congestive Heart Failure |
CT Angiography |
Echocardiography |
Electrophysiology |
Cardiology General |
Genetics |
Health Economics |
Hypertension |
Interventional Cardiology |
MRI |
Nuclear Cardiology |
Peripheral Arterial Disease |
Prevention |
Public Policy |
Pulmonary Embolism |
Stable Angina |
Valvular Heart Disease |
Vascular Medicine |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor in Chief: Cafer Zorkun, M.D., Ph.D. [2]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Cardiotoxicity is the occurrence of heart muscle damage. The heart becomes weaker and is not as efficient in pumping and therefore circulating blood. Cardiotoxicity may be caused by chemotherapy treatment, complications from anorexia nervosa, drugs or chemical toxins.
Cobalt
Cocaine
Interferon alpha
Interleukin-2
Phenothiazines
- Electrocardiographic changes
- Arrhythmias
- Sudden cardiac death
Emetine
- Mononuclear and histiocyte infiltration
- Electrocardiographic abnormalities
Methysergide
- Left-sided valvular lesions
- Fibrotic endocardial lesions
- Fibrotic pericardial lesions
- Restriction
- Pericardial constriction
Chloroquine
- Arrhythmias
- Cardiac dysfunction
Lithium
- Arrhythmias
- Cardiac dilatation with myofibrillar degeneration
Hydrocarbons
- Electrocardiographic changes
- Arrhythmias
- Cardiomegaly
Lead
- Electrocardiographic changes
- Arrhythmias
- Congestive heart failure
Carbon monoxide
- Arrhythmias
- Transient biventricular dysfunction
Polychlorinated biphenyls (PCBs)
- Pericardial effusion in chronic exposure
- Edema PCBs may interfere with tissue permeability or cardiac function or both. [1]
Barbiturates
References
See also
External Links
- Chemocare.com: [4]